ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

CMMB Chemomab Therapeutics Ltd

0.7254
0.00 (0.00%)
Pre Market
Last Updated: 03:05:07
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Chemomab Therapeutics Ltd CMMB NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 0.7254 03:05:07
Open Price Low Price High Price Close Price Previous Close
0.7254
more quote information »

Recent News

Date Time Source Heading
4/24/202406:00GLOBEChemomab Therapeutics to Report First Quarter 2024 Financial..
4/18/202406:00GLOBEChemomab Reports New Peer-Reviewed Publication Reinforcing..
4/02/202406:00GLOBEChemomab to Host Virtual Key Opinion Leader Webinar on..
3/25/202406:06GLOBEChemomab Awarded New European Patent for CM-101, Its..
3/07/202406:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
3/07/202406:00PRNUSChemomab Therapeutics Announces Year End and Fourth Quarter..
3/05/202406:00PRNUSChemomab Therapeutics to Participate in Leerink Global..
2/20/202408:20APSBiotech Shares Massively Bid Up Before Opening Bell
2/20/202406:00PRNUSChemomab Awarded New Patents for CM-101, Its First-in Class..
2/14/202406:00PRNUSChemomab Therapeutics to Report Fourth Quarter and Full Year..
2/05/202406:00PRNUSChemomab Therapeutics to Participate in Upcoming Investor..
1/30/202406:00PRNUSChemomab Therapeutics Announces New Publication Reinforcing..
1/03/202406:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/03/202406:00PRNUSChemomab Announces Completion of Patient Enrollment in..
11/16/202306:00PRNUSChemomab Presentation at ACR Convergence 2023 Provides..
11/15/202315:35EDGAR2Form SC 13D/A - General statement of acquisition of..
11/15/202306:00PRNUSChemomab Therapeutics Receives FDA Fast Track Designation..
11/13/202307:00PRNUSChemomab Presents New Clinical Data Supporting CM-101's..
11/09/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/09/202307:00PRNUSChemomab Therapeutics Announces Third Quarter 2023 Financial..
11/06/202315:15PRNUSChemomab Therapeutics Discloses Receipt of Nasdaq Notice..
11/05/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
10/30/202307:33EDGAR2Form F-3/A - Registration statement by foreign private..
10/30/202306:00PRNUSChemomab Therapeutics to Report Third Quarter 2023 Financial..
10/26/202306:00PRNUSChemomab Therapeutics to Present at Upcoming Scientific..
10/16/202315:25EDGAR2Form F-3 - Registration statement by foreign private issuers
9/28/202306:00PRNUSChemomab Therapeutics to Present Its CM-101 Clinical Program..
8/29/202306:00PRNUSChemomab Therapeutics to Present at the H.C. Wainwright 25th..
8/14/202307:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/14/202307:00PRNUSChemomab Therapeutics Announces Second Quarter 2023..
8/08/202305:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/05/202316:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/03/202314:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
6/28/202306:00PRNUSChemomab Therapeutics Announces Publication in JCI Insight..
6/26/202306:00PRNUSChemomab Therapeutics Presents Data Reinforcing the Clinical..
6/21/202306:00PRNUSChemomab Therapeutics Reports Positive Data from Secondary..
6/05/202306:00PRNUSChemomab Therapeutics Announces Executive Leadership Changes..
6/02/202308:00PRNUSPatient Data Presented at 2023 EULAR Congress Highlights How..
5/24/202306:00PRNUSChemomab Therapeutics to Participate in Upcoming Scientific..
5/11/202305:00PRNUSChemomab Therapeutics Announces First Quarter 2023 Financial..

Your Recent History

Delayed Upgrade Clock